New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
09:25 EDTMYL, MYL, ATI, ATI, IIVI, IIVI, KOP, KOP, ANSS, ANSS, FSTR, FSTR, BBOX, BBOX, KMT, KMT, STBA, STBA, CCC, CCC, EQT, EQT, WCC, WCCCFA Society of Pittsburgh to hold a conference
2014 INVESTPennsylvania Equity Conference to be held in Pittsburgh on May 29 with webcasted company presentations to begin at 9:25 am; not all company presentations may be webcasted. Webcast Link
News For MYL;EQT;CCC;STBA;KMT;BBOX;FSTR;ANSS;KOP;IIVI;ATI;WCC From The Last 14 Days
Check below for free stories on MYL;EQT;CCC;STBA;KMT;BBOX;FSTR;ANSS;KOP;IIVI;ATI;WCC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
11:22 EDTMYLMylan ANDA for three times per week generic Copaxone accepted by FDA for filing
Mylan (MYL) announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration. This product is the generic version of Teva's (TEVA) Copaxone 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis. Mylan believes it is one of the first companies to have filed a substantially complete ANDA containing a Paragraph IV certification for this product and expects to be eligible for 180 days of marketing exclusivity in the U.S. upon final FDA approval. Copaxone 40 mg/mL had U.S. sales of approximately $411.5M for the 12 months ending June 30, 2014, according to IMS Health.
August 26, 2014
07:29 EDTBBOXThree Part Advisors to hold a conference
Midwest IDEAS Conference to be held in Chicago on August 26-27.
August 22, 2014
08:02 EDTMYLMylan launches first generic Klor-Con Extended-release tablets
Subscribe for More Information
August 20, 2014
11:44 EDTMYLMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
11:33 EDTMYLMylan into second round of bidding for GSK drug portfolio, WSJ reports
Subscribe for More Information
08:12 EDTEQTEQT Corporation management to meet with Deutsche Bank
Subscribe for More Information
August 19, 2014
11:44 EDTMYLMylan launches generic Precedex Injection
Subscribe for More Information
08:11 EDTKMTKennametal announces departure of CEO Carlos Cardoso
Kennameta announced that Chairman, President and CEO Carlos Cardoso has decided to retire from the company effective on December 31. This will be a seamless leadership transition as the company's board of directors commences its search for Cardoso's successor, which members expect to complete before the end of the year. The search process will consider both internal and external candidates.
August 18, 2014
10:06 EDTMYLLannett surges after upbeat Q4, FY14 outlook
Subscribe for More Information
August 15, 2014
14:21 EDTKOPKoppers completes Wood, Railroad acquisition from Osmoe, sees $12M in synergies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use